Skip to main content
. Author manuscript; available in PMC: 2021 Jan 23.
Published in final edited form as: J Am Geriatr Soc. 2019 Nov 28;68(3):614–618. doi: 10.1111/jgs.16264

Table 1.

Regression Results Estimating Change in Falls Self-Efficacy Score Over Time and by Age and Treatment Group

FSE change
Participants Randomized group Points per year 95% CI P value for time × treatment interaction P value for time × age group interaction
Model 1a All Intensive .11 (.05 to .17) .95 NA
Standard .11 (.05 to .17)
<75 y Intensive .01 (−.06 to .08) .55 <.0001
Standard .05 (−.02 to .12)
≥75 y Intensive .34 (.24 to .45)
Standard .25 (.14 to .36)
Model 2a All Intensive .12 (.06 to .18) .71 NA
Standard .11 (.05 to .17)
<75 y Intensive .03 (−.05 to .10) .47 <.0001
Standard .05 (−.02 to .12)
≥75 y Intensive .35 (.24 to .46)
Standard .26 (.15 to .37)

Abbreviations: CI, confidence interval; FSE, falls self-efficacy score; NA, not applicable.

a

Model 1 adjusted only for treatment and time; model 2 adjusted for treatment, time, age > 75 years, sex, black race, Hispanic ethnicity, cardiovascular disease history, chronic kidney disease status, systolic blood pressure tertile, Veterans RAND 12 Item Health Survey physical and mental scores, Patient Health Questionnaire-9 score, number of chronic diseases, body mass index, living with others, and frailty status.